Healthcare & Life Sciences
Bonti
United States
acquiredacquired
acquired
Stage
About
Bonti was a biotechnology company specializing in therapeutics, acquired by Allergan in 2018 for $285 million. The company had board involvement from Alexey Konov prior to acquisition.
Explore Bonti's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.